The p38 mitogen-activated protein kinase (MAPK) signaling pathway, which regulates the activity of different transcriptions factors including NF-kB, is activated in lesional psoriatic skin. The purpose of this study was to investigate the effect of fumaric acid esters (FAEs) on the p38 MAPK and the downstream kinases mitogen-and stress-activated protein kinase (MSK)1 and 2 in cultured human keratinocytes. Cell cultures were incubated with dimethylfumarate (DMF), methylhydrogenfumarate (MHF), or fumaric acid (FA) and then stimulated with IL-1b before kinase activation was determined by Western blotting. A significant inhibition of both MSK1 and 2 activations was seen after preincubation with DMF and stimulation with IL-1b, whereas MHF and FA had no effect. In addition, DMF decreased phosphorylation of NF-kB/p65 (Ser276), which is known to be transactivated by MSK1. Furthermore, incubation with DMF before stimulation with IL-1b resulted in a significant decrease in NF-kB binding to the IL-8 kB and the IL-20 kB-binding sites as well as a subsequent decrease in IL-8 and IL-20 mRNA expression. Our results suggest that DMF specifically inhibits MSK1 and 2 activations and subsequently inhibits NF-kB-induced gene-transcriptions, which are believed to be important in the pathogenesis of psoriasis. These effects of DMF explain the anti-psoriatic effect of FAEs.
INTRODUCTION
Various combinations of fumaric acid esters (FAEs) have been used empirically for oral treatment of psoriasis for more than 40 years (Mrowietz and Asadullah, 2005) . In 1989, the efficacy of dimethylfumarate (DMF) in psoriasis was demonstrated for the first time in a controlled study (Nieboer et al., 1989) and in 1994 a mixture of different FAEs (including DMF and methylhydrogenfumarate (MHF)) was registered in Germany as Fumaderm s initial (low-strength tablets) and Fumaderm s (high-strength tablets) for systemic treatment of severe psoriasis. DMF and, in part, MHF or their metabolites are considered to be the main active ingredients of Fumaderm s . Fumaderm s has become the number one drug for systemic therapy in Germany (Mrowietz and Asadullah, 2005 ) although its precise mechanism of action is still unknown.
A number of studies have tried to elucidate the mode of action of FAEs in psoriasis. FAEs have been shown to induce a shift of the immunological balance from a T helper 1-towards a T helper 2-like response (De Jong et al., 1996) , and especially DMF has been shown to inhibit the transcription and protein expression of different inflammatory mediators including IL-8, Mig, and IP-10 in peripheral blood mononuclear cells (Ockenfels et al., 1998) and in normal human keratinocytes (Stoof et al., 2001) . In human umbilical vein endothelial cells, DMF has also been shown to modulate adhesion molecule expression by blocking tumor necrosis factor (TNF)a-induced expression of ICAM-1, vascular cell adhesion molecule-1, and E-selectin (Vandermeeren et al., 1997) . Furthermore, DMF has been shown to induce apoptosis in U937-cells (Sebok et al., 2000) , and in purified human T cells (Treumer et al., 2003) . The cellular redox system is also modulated by FAEs. In animal experiments, where DMF was added to the diet, a significant modulation of intracellular levels of detoxifying enzyme systems like the reduced glutathione (GSH)oxidized glutathione-disulfide (GSSG) system were seen (Spencer et al., 1990) . In particular, an upregulation of the GSH level was seen after dietary supplementation.
NF-kB is a dimeric nuclear transcription factor also regulated by FAEs in vitro. Interestingly, a dysregulation of NF-kB activation in lesional psoriatic skin compared with nonlesional psoriatic skin has been demonstrated (Johansen et al., 2005a) . Furthermore, downregulation of NF-kB transcriptional activity has been suggested as a possible mode of action of anti-TNFa therapy for psoriasis (Lizzul et al., 2005) .
NF-kB is a dimer formed by members of the NF-kB/Rel family of proteins, consisting of p50, p52, p65, c-Rel, and RelB (Liou and Baltimore, 1993; Baeuerle and Henkel, 1994) . In resting cells, NF-kB is retained in the cytoplasm as an inactive complex with inhibitor kB, which masks the nuclear localization sequences of NF-kB (Baldwin, 1996) . Thus, cellular stimulation results in phosphorylation, ubiquitination, and subsequent degradation of inhibitor kB, unmasking the nuclear localization sequences, and leaving NF-kB free to translocate into the nucleus where it binds to specific kB-binding sites in its target genes (Pahl, 1999) .
Recently, DMF has been shown to prevent selectively the nuclear entry of activated NF-kB in TNFa-stimulated human endothelial cells (Loewe et al., 2002) . In human dendritic cells, both DMF and MHF have an inhibitory effect on lipopolysaccharide-induced NF-kB activation (Litjens et al., 2004) .
NF-kB is believed to play a pivotal role in immune and inflammatory responses by stimulating the expression of a number of adhesion molecules as well as proinflammatory cytokines and chemokines (Karin and Ben-Neriah, 2000) . NF-kB activation also results in a protective effect against apoptotic cell death (Sonenshein, 1997) . Furthermore, an increased GSH level inhibits NF-kB activation (Perl et al., 2002) . In view of these observations, inhibition of NF-kB has recently been suggested as the molecular target of DMF and MHF in psoriasis (Mrowietz and Asadullah, 2005) .
Recently, increased kinase activity of the p38 mitogenactivated protein kinase (MAPK) cascade has also been demonstrated in lesional psoriatic skin compared with nonlesional psoriatic skin (Johansen et al., 2005b) , and has been suggested to play an important role in the pathogenesis of psoriasis (Arthur and Darragh, 2006) . The p38 MAPK cascade is able to activate additional downstream kinases and at least two of these downstream kinases, MAPKactivated protein kinase 2 (MK2) and mitogen-and stressactivated protein kinase 1 (MSK1), are activated in lesional psoriatic skin Funding et al., 2006) . MK2 is thought to control cytokine production at a posttranscriptional level, whereas MSK1 and the related kinase MSK2 regulate gene transcription through transactivation of different transcription factors. MSK1 has been shown to phosphorylate various transcription factors including cAMP-response element-binding protein (CREB) (Deak et al., 1998) , the CREB-related protein, ATF-1 (Wiggin et al., 2002) , and the p65 subunit of NF-kB at Ser276 (Vermeulen et al., 2003) leading to increased transcriptional activity.
The purpose of this study was, therefore, to investigate the effect of FAEs on the p38 MAPK signaling pathway including some of its downstream kinases in cultured normal human keratinocytes. In this paper, we demonstrate for the first time that DMF, but not MHF, specifically inhibits MSK1 and 2 activation and NF-kB/p65 transactivation through inhibition of Ser276 phosphorylation, whereas no changes in p38 MAPK and MK2 activation were seen. DMF may, therefore, inhibit both NF-kB nuclear translocation and NF-kB transactivation and thereby exert its anti-psoriatic effect.
RESULTS
Effect of DMF, MHF, and FA on IL-1b-induced p38 MAPK, ERK p44/p42, and MK2 activation in normal human keratinocytes in vitro
To investigate the protein level of activated p38 MAPK, whole-cell extracts from IL-1b-stimulated cultured normal human keratinocytes were isolated and analyzed by Western blotting using an anti-phospho-p38 MAPK (Thr180/Tyr182) antibody. IL-1b (20 ng/ml) stimulation resulted in a pronounced activation of the p38 MAPK at 5, 15, and 30 minutes after stimulation compared with vehicle. Thus, no significant changes in p38 MAPK activation were seen after preincubation with DMF (140 mM), MHF (140 mM), or FA (140 mM) for 1 hour and no changes were seen in the expression of total p38 MAPK ( Figure 1a ). These findings were confirmed by densitometric analysis of band intensity of the Western blots (data not shown).
The extracellular signal-regulated kinase (ERK) p44/p42 is another MAPK which regulate cell proliferation. ERK p44/p42 activation in whole-cell extracts from cultured normal human keratinocytes preincubated with vehicle, DMF (140 mM), MHF (140 mM), or FA (140 mM) for 1 hour before stimulation with IL-1b (20 ng/ml) for various time points were analyzed by Western blotting using an anti-phospho-ERK p44/p42 (Thr202/Tyr204) antibody. After stimulation for 5 minutes, a significant activation of both ERK p44 and p42 was seen ( Figure 1b ). However, no changes in ERK p44/p42 activation were seen after preincubation with DMF, MHF, and FA. Equal protein loading was confirmed by detection of total ERK p44/p42 ( Figure 1b ).
MK2 is a serine/threonine kinase that is activated by the p38 MAPK through phosphorylation at threonine 334 (Roux and Blenis, 2004) . In experiments conducted as described above, stimulation with IL-1b (20 ng/ml) of cultured normal human keratinocytes resulted in MK2 activation after 5 and 15 minutes determined by Western blotting using an antiphospho-MK2 (Thr334) antibody. Again, preincubation with DMF (140 mM), MHF (140 mM), or FA (140 mM) before IL-1b stimulation did not result in any significant changes in MK2 activation ( Figure 1c ). Equal protein loading was confirmed by detection of total MK2. Effect of DMF, MHF, and FA on IL-1b-induced MSK1 and 2 activations in normal human keratinocytes in vitro MSK1 and 2 are activated by both p38 MAPKs and ERK p44/ 42. In keratinocytes, however, the IL-1b-induced MSK1 activation is only dependent on the p38 MAPK signaling pathway . MSK1 is activated by phosphorylation at Ser376 and Thr581 (McCoy et al., 2005) . Equivalent amounts of whole cell protein extracts from cultured normal human keratinocytes preincubated with either vehicle, DMF (140 mM), MHF (140 mM), or FA (140 mM) and then stimulated with IL-1b (20 ng/ml) for various time points were analyzed by Western blotting using antiphospho-MSK1 (Ser376). Stimulation with IL-1b resulted in a significant activation of MSK1 after stimulation for 15 and 30 minutes (Figure 2a ). Thus, preincubation with DMF consistently and significantly inhibited MSK1 activation, whereas MHF or FA did not result in any significant changes in MSK1 activation (Figure 2a ). MSK1 and MSK2 are closely related nuclear kinases, and results indicate that MSK1 and 2 may be able to compensate functionally for each other (Wiggin et al., 2002) . In IL-1bstimulated keratinocytes, MSK2 was also activated at 15-30 minutes after stimulation. Preincubation with DMF before IL-1b stimulation significantly abolished MSK2 phos-phorylation at Ser196, whereas MHF and FA had no effect ( Figure 2b) .
In dose-finding experiments, keratinocyte cultures were preincubated with 7, 70, or 140 mM DMF before stimulated with IL-1b 20 ng/ml for 15 and 30 minutes. There was a dosedependent inhibition of MSK1 (Ser376) phosphorylation with a maximal inhibition at 140 mM DMF ( Figure 2c ).
Furthermore, cell viability was tested by lactate dehydrogenase (LDH) release in cells incubated with or without 140, 70, or 7 mM DMF for 1 hour and stimulated with IL-1b for 30 minutes. No significant difference was found between control cells and cells incubated with DMF (Table 1) .
Effect of DMF, MHF, and FA on IL-1b-induced phosphorylation of CREB and the CREB-related protein, ATF-1 CREB and activation transcription factor 1 (ATF1) are both transcription factors activated through the MSK1 and 2 signaling pathway (Deak et al., 1998; Wiggin et al., 2002) .
To study the effect of FAEs on MSK1 and 2 downstream . Cultured normal human keratinocytes were preincubated with 140 mM of DMF, MHF, or FA for 1 hour and then stimulated with 20 ng/ml of IL-1b for 5, 15, 30 minutes or 2 hours. Whole-cell extracts (50 mg of protein) were isolated and separated by SDS-PAGE on 10-20% gradient gels. After electroblotting, the separated proteins were probed with (a) anti-phospho p38, (b) anti-phospho-ERK1/2, (c) or antiphospho-MK2. Blots were then stripped and equal loading was confirmed by incubation with anti-p38, anti-ERK1/2, or anti-MK2 antibodies. As a positive control (pc) for phospho-MK2 keratinocytes were stimulated for 5 minutes with anisomycin (0.5 mg/ml). One representative Western blot out of four is shown. Whole cell-extracts (50 mg of protein) were isolated and separated by SDS-PAGE on 10-20 % gradient gels. After electroblotting, the separated proteins were probed with (a and c) anti-phospho-MSK1 (Ser376) or (b) antiphospho-MSK2 (Ser196). Blots were then stripped and equal loading was confirmed by reincubation with anti-MSK1 and -MSK2 antibodies. As a positive control (pc) keratinocytes were stimulated for 15 minutes with anisomycin (0.5 mg/ml). One representative Western blot out of five is shown. Western blotting of equivalent amounts of whole-cell extracts was performed and analyzed for phospho-CREB (Ser133) and total CREB expression. Equal protein loading was confirmed by detection of total b-actin. IL-1b stimulation resulted in a consistent and significant increase in CREB phosphorylation at 5, 15, and 30 minutes ( Figure 3a ). Preincubation with DMF strongly and significantly inhibited CREB phosphorylation at Ser133 (Figure 3a ). Densitometric analysis of band intensity confirmed the significant decrease at all time points in phospho-CREB expression in keratinocytes preincubated with DMF and stimulated with IL-1b compared with controls ( Figure 3c ). Preincubation with DMF also lead to consistent and, after 15 minutes of stimulation with IL-1b, also significant decrease in total CREB expression compared with controls ( Figure 3a and d) . When expressing phospho-CREB relative to total CREB, a significant decrease in phospho-CREB expression was seen only before IL-1b stimulation and after 5 minutes of stimulation ( Figure 3b ). No effect of preincubation with neither MHF nor FA was seen ( Figure 3a) .
The anti-phospho-CREB antibody also detects the phosphorylated form of the CREB-related protein, ATF-1, and similarly to CREB, pre-incubation with DMF resulted in a significant inhibition in the IL-1b-induced phosphorylation of ATF-1, whereas no effects were seen on preincubation with MHF or FA ( Figure 3 ). Equal protein loading was demonstrated by detection of b-actin. (Figure 4a ) and the cytosolic (Figure 4b ) fraction after stimulation for 15 and 30 minutes. Furthermore, a significant increase in total p65 was seen in the nuclear fraction after IL-1b stimulation (Figure 4a ). Preincubation with DMF strongly inhibited p65 phosphorylation at Ser276 in both the nuclear (Figure 4a ) and the cytosolic (Figure 4b) fraction. Furthermore, DMF clearly inhibited p65 translocation into the nucleus (Figure 4a ). Preincubation with neither FA nor MHF resulted in any significant changes in p65 phosphorylation or NF-kB nuclear translocation.
To asses the purity of the nuclear and the cytosolic fraction, lamin B was used as marker for nuclear protein (Brasier et al., 2001) . Using an anti-lamin B antibody, there was reactivity in the nuclear fraction but not in the cytosolic fraction (Figure 4) . Nuclear fractions were isolated from keratinocytes preincubated with either vehicle, DMF (140 mM), MHF (140 mM), or FA (140 mM) before being stimulated with IL-1b (20 ng/ml) or vehicle for 0 or 30 minutes. Nuclear fractions from cultured keratinocytes were incubated with an oligonucleotide containing the kB-binding site from the IL-8-promotor region or an oligonucleotide containing one of the two recently identified kB-binding sites in the IL-20 promoter (see Materials and Methods) and analyzed by electrophoretic mobility shift assay. Supershift analyzes of the NF-kB-binding complexes were also carried out using antibodies directed against the p65 or the p50 proteins.
IL-1b stimulation for 30 minutes significantly induced NF-kB binding to the IL-8 motif as well as the two IL-20 kB motifs ( Figure 5 ). Preincubation with DMF significantly inhibited NF-kB binding to the IL-8 kB-binding motif (Figure 5a) as well as to one of the two identified IL-20 kB (B1)-binding motifs (Figure 5b and c) . Preincubation with MHF or FA did not result in any changes in the NF-kB binding to the tested kBbinding sites. Supershift experiments showed that addition of an anti-p65 antibody resulted in a complete shift of both the IL-8 kB complex as well as the two IL-20 kB complexes, whereas addition of an anti-p50 antibody only partly shifted the binding to the IL-8 kB complex (Figure 5a-c) .
DMF inhibits IL-1b-induced IL-8 and IL-20 mRNA expression IL-1b-induced IL-8 and IL-20 mRNA expression in cultured human keratinocytes is dependent on NF-kB activation (Johansen et al., 2005a; Otkjaer et al., 2005 Otkjaer et al., , 2007 . Because DMF inhibits NF-kB binding to the IL-8-and IL-20 kBbinding sites and also inhibits NF-kB transactivation, experiment were conducted to determine the effect of DMF on IL-1b-induced IL-8 and IL-20 mRNA expression in cultured normal human keratinocytes. Keratinocytes were preincubated with or without DMF (140 mM) for 1 hour before stimulation with IL-1b (20 ng/ml). IL-8 and IL-20 mRNA expression at 12 and 1 hour respectively were analyzed by quantitative reverse transcription-PCR and showed a consistent and significant inhibition of both IL-8 and IL-20 mRNA expression in cells preincubated with DMF (n ¼ 4) ( Figure 6 ). IL-20 mRNA expression was inhibited to approximately basal level ( Figure 6 ).
DISCUSSION
In this study, we have presented three interesting and novel observations all of which provide new important information regarding the mechanism of action of DMF in psoriasis. First, DMF specifically inhibits IL-1b-induced MSK1 and 2 activations in normal cultured human keratinocytes, whereas other kinases within the p38 MAPK signaling pathway were not affected. Second, DMF was shown to inhibit transactivation of transcription factors such as NF-kB, CREB, and ATF1, which are all downstream targets of the MSK1 and 2 signaling pathway; and finally, DMF has been shown to inhibit IL-1binduced expression of IL-8 and IL-20 mRNA, both genes activated by NF-kB.
MSK1 is expressed in epidermal keratinocytes and has been shown to be highly activated in lesional psoriatic skin . It has been suggested to play a key role in the pathogenesis of psoriasis (Arthur and Darragh, 2006; Funding et al., 2006) . MSK1 is activated by the p38 MAPK or the ERK p44/42 MAPKs through phosphorylation of either Ser376 or Thr581 and phosphorylation of Ser376 is required for MSK1 activation (Chrestensen and Sturgill, 2002) . MSK2 is not as well characterized as MSK1 although MSK2 is 75% identical to MSK1 (Vermeulen et al., 2002) . MSK2 is activated through phosphorylation of Ser196 (Roux and Blenis, 2004) , and evidence from knockout mice has suggested an overlapping effect of MSK1 and MSK2. It is, therefore, interesting that DMF inhibits IL-1b-induced activation of both MSK1 and 2. Inhibition of MSK1 and 2 activations was not seen when cells were preincubated with MHF or FA strongly supporting that DMF or one of its metabolites is the active compound in the mixture of FAEs used in psoriasis (Nieboer et al., 1989) . Furthermore, the inhibitory effect of DMF on MSK 1 and 2 was specific, because other kinases such as p38 MAPK, ERK p44/p42 MAPK, and MK2 were not affected. The DMF concentration causing maximal inhibition of MSK1 and MSK2 activation in keratinocytes was similar to that found in T cells (Treumer et al., 2003) .
Activation of NF-kB by proinflammatory stimuli leads to the expression of genes inducing and maintaining inflammation and NF-kB has been shown to be activated at sites of inflammation in a variety of diseases including psoriasis (Tak and Firestein, 2001; Johansen et al., 2005a, b; Lizzul et al., 2005) . Therefore, NF-kB is considered a potential target for treating inflammatory diseases.
In previous studies in endothelial cells, DMF was shown to inhibit TNF-induced gene expression through a mechanism involving NF-kB inhibition (Loewe et al., 2001; Vandermeeren et al., 2001) . The NF-kB inhibition was mediated through an inhibition of TNFa-induced nuclear entry of p65, whereas there was no inhibition of the TNFa-induced signaling to IkB (Loewe et al., 2001 (Loewe et al., , 2002 . Therefore, DMF was concluded to inhibit NF-kB activation by interfering with translocation of NF-kB to the nucleus. A similar mechanism of action was demonstrated in normal human keratinocytes in this study (Figure 4 ). Besides interfering with NF-kB nuclear entry, DMF inhibited NF-kB transactivation through inhibition of MSK1 and 2 activities. This has never been demonstrated before. MSK1 has previously been shown to phosphorylate NF-kB/ p65 at Ser276 in mouse fibroblasts (Vermeulen et al., 2002 (Vermeulen et al., , 2003 and similar results were obtained in this study in cultured normal human keratinocytes. Interestingly, phosphorylation of NF-kB/p65 at Ser276 has been shown to be Figure 5 . Effect of DMF, MHF, and FA on NF-jB DNA binding. Cultured human keratinocytes were pr-incubated with 140 mM of DMF, MHF, or FA for 1 hour and then stimulated with 20 ng/ml of IL-1b for 30 minutes. Nuclear proteins were prepared and 5 mg of protein was incubated with a labeled oligonucleotide identical to either the kB site from the (a) IL-8 promoter or (b) the IL-20 promoter site B, and (c) B1. The NF-kB-binding activity was then determined by electrophoretic mobility shift assay. Supershift analysis of the NF-kB dimers was carried out. Antibodies for p65 and p50 were added 10 minutes before the labeled oligonucleotides. One representative Western blot out of three is shown. essential for transcriptional activation by MSK1 (Vermeulen et al., 2003) . Inhibition of Ser276 phosphorylation of NF-kB/ p65 by DMF is therefore a novel mechanism of action by which DMF inhibits NF-kB activation. MSK1 is regarded a nuclear kinase for NF-kB/p65 (Vermeulen et al., 2003) and this explains why DMF was able to inhibit phosphorylation of the nuclear p65 at Ser276. Recently, MSK1 was also identified in the cytoplasm , which may explain why DMF inhibited NF-kB/ p65 phosphorylation at Ser276 in the cytosolic fraction (Figure 4) . The localization of MSK2 has not yet been investigated in the skin.
MSK1 and 2 phosphorylate various other transcription factors including CREB and ATF1 (Deak et al., 1998; Pierrat et al., 1998; Wiggin et al., 2002) . Our results showed increased phosphorylation of both CREB and ATF1 after stimulation of normal cultured human keratinocytes with IL-1b. Furthermore, preincubation with DMF in IL-1b-stimulated cultures inhibited both CREB and ATF1 phosphorylation (Figure 3) , most probably through an inhibition of MSK1 and 2 activations. Thus, we also observed lower levels of total CREB in the DMF-treated cells. These results are in agreement with Mouravlev et al. (2006) , which showed that phosphorylation at Ser133 prevented CREB degradation in human embryonic kidney cells. Similarly, the stability of ATF2, which shares 65% homology with CREB, was shown to be regulated by phosphorylation and dephosphorylation (Fuchs et al., 2000) . Therefore, the lower levels of total CREB in the DMF þ IL-1b-treated cells compared with IL-1b alone (Figure 3) can be explained by the fact that DMF inhibits MSK1and 2-induced CREB phosphorylation and thereby indirectly stimulates CREB degradation. Interestingly, a very recently published study (Schiller et al., 2006) showed that MSK1 is critical for IL-1-induced CREB-mediated, c-fos gene expression in the human keratinocyte cell line HaCaT. Our results, therefore, suggest that specific inhibition of MSK1 and 2 is a key mode of action by which DMF inhibits transactivation of different transcriptions factors regulating the expression of proinflammatory genes.
DMF has previously been shown to inhibit IL-8 expression in lipopolysaccharide-stimulated peripheral blood mononuclear cells (Ockenfels et al., 1998) . In cultured normal human keratinocytes, pretreatment with DMF before stimulation with phorbol-ester or INFg resulted in an inhibition of both IL-8 mRNA and protein expression (Stoof et al., 2001) . These results are in agreement with results obtained in this study. Thus, we found an inhibition of NF-kB binding to a possible IL-20 kB1-binding site as well as a pronounced inhibition of IL-20 mRNA expression after preincubation with DMF and stimulation with IL-1b ( Figures 5 and 6 ). IL-20 mRNA expression was inhibited to a level comparable with unstimulated cells. IL-20 is a recently discovered cytokine belonging to the IL-10 family of cytokines (Blumberg et al., 2001) . It is expressed in the skin and IL-20 mRNA has been shown to be upregulated in lesional psoriatic skin compared with nonlesional psoriatic skin (Romer et al., 2003; Otkjaer et al., 2005) . Furthermore, IL-20 mRNA expression decreases in parallel with clinical and histological improvement of the skin during treatment (Otkjaer et al., 2005) . Therefore, IL-20 has been suggested as a key cytokine in the pathogenesis of psoriasis (Blumberg et al., 2001; Otkjaer et al., 2005) and inhibition of IL-20 expression may also be an important part of the anti-psoriatic effect of DMF.
New results (Otkjaer et al., 2007) have shown that IL-1binduced IL-20 mRNA and protein expression is regulated through p38 MAPK-and NF-kB-dependent pathways. The pronounced inhibitory effect of DMF on IL-20 expression is therefore, most probably owing to its inhibitory effect on both NF-kB translocation and p38 MAPK/MSK1-and 2-mediated transactivation of NF-kB.
Taken together, the results presented in this study add new information regarding the mode of action of DMF in the treatment of psoriasis. Our findings identify DMF as the pharmacologically active compound when compared with MHF and FA regarding inhibition of NF-kB nuclear translocation and inhibition of NF-kB transactivation are suggested as key mechanisms of action of DMF.
MATERIALS AND METHODS

Cell cultures
Normal adult human keratinocytes were obtained by trypsinization of skin samples from patients undergoing plastic surgery as described previously (Kragballe et al., 1985) . First passage keratinocytes were grown in keratinocyte serum-free medium (Invitrogen, Carlsbad, CA). Twenty-four hours before IL-1b stimulation (20 ng/ml; R&D Systems, Oxon, UK), the medium was changed to keratinocyte basal medium (the same as keratinocyte serum-free medium but without growth factors) in which the cells were stimulated. Cells were grown at 371C and 5% CO 2 in an incubator.
The study was conducted according to the institutional approval of experiments, patient consent and adherence to the Declaration of Helsinki Principles.
DMF and calcium methyl hydrogen fumarate (Fumapharm, Luzern, Switzerland) and FA (F8509, Sigma Aldrich) were solubilized in DMSO (Art. 2951, Merck) and diluted to 70 mM stock solutions (2% v/v DMSO) in keratinocyte basal medium. Treatment of cells with DMF, MHF, and FA were further diluted in medium for final concentrations 7, 70, and 140 mM. All stock solutions were freshly made 10 minutes before use. Cells were preincubated with DMF, MHF, or FA 1 hour before stimulation with IL-1b (R&D Systems).
Western blotting
Cells were washed two times with ice-cold PBS buffer and kept at À801C until further treatment. Whole-cell extracts were prepared in sample buffer (50 mM Tris-HCl, 10% glycerol, 2.5% SDS, 10 mM dithioerythritol, 10 mM b-glycerophosphate, 10 mM NaF, 100 mM Na orthovanadate, 7 M urea; U-6504, Sigma) with 1 ml benzonase (Merck 1.01654.001)/100 ml sample buffer. Equal load of protein (determined by Bradford) was separated on precast SDS-PAGE, 8-16 or 10-20% Tris-glycine gels. (Invitrogen, Denmark; EC60452 box or EC61352 box). Generally, 50 mg of protein was applied to gels. Equal load was controlled by antibody for b-actin (A-1978, Sigma). Alternatively, nuclear lysates were prepared according to Johansen et al. (2000 Johansen et al. ( , 2005a . The purity of the nuclear and cytosolic lysates was controlled by antibody for lamin B (Santa Cruz Biotechnology, Santa Cruz, CA). Proteins were blotted onto hybond enhanced www.jidonline.org 2135 B Gesser et al.
Anti-Psoriatic Effect DMF chemoluminescence nitrocellulose membrane (RPN2020D; Amersham Bioscience, GE Healthcare, Denmark) blocked and developed according to the instructions from Cell Signaling Technology (Beverly, MA) for the specific antibody. The antibody binding was visualized by horseradish peroxidase-conjugated second antibody in a standard ECL TM (RPN 2106) reagent on Hyperfilm TM enhanced chemoluminescence (RPN 3103K; Amersham Bioscience and Denmark). Densitometric analysis of the band intensity was carried out using Kodak one-dimensional imaging analysis software.
The following antibodies were used: anti-p38 MAPK and antiphospho-p38 MAPK (Thr180/Tyr182), anti-MAPKAP2 and antiphospho-MK2 (Thr334) mRab, anti-ERK1/2, and anti-ERK1/2 (Thr 202/Tyr 204), anti-phospho-MSK1 (Ser376), anti-MSK2, and antiphospho-MSK2 (Ser196), anti-NF-kB p65 and anti-phopho-NF-kB p65 (Ser276), anti-CREB (no. 9197), and anti-phospho-CREB (Ser133) and horseradish peroxidase anti-rabbit no. 7074 were from Cell Signaling Technology, anti-MSK1 (H-19) from Santa Cruz Biotechnology (Santa Cruz, CA). Horseradish peroxidase-labeled swine anti-rabbit P0217, anti-goat P0449, anti-mouse P0447 were from Dako Cytomation (Copenhagen, Denmark). Anti-phospho-MSK2 (Ser196)/RSKB and anti-MSK-2/RSKB were from R&D Systems.
LDH release membrane integrity assay
LDH released from cells with compromised membranes was assayed using the CytoTox-One TM homogeneous membrane integrity assay (G7891, Promega, Denmark). Keratinocyte, 10,000 cells/well in triplicates, in 96-well plates were stimulated as described above and after 30 minutes stimulation with vehicle or IL-1b, 100 ml of CytoTox-One reagent was added to each well and LDH assay was allowed to proceed for 10 minutes before addition of 50 ml/well stop solution. Flourescence was recorded at a wavelength of 590 nm using Fluoroskan Ascent Fl (Labsystems, Serial: 374020271C, Denmark). Maximum LDH release control was 2 ml of lysis solution added to positive control cells before addition of reagent. Percent cytotoxicity was calculated as ratio 100 Â experimental/maximum LDH release.
Electrophoretic mobility shift assay
Electrophoretic mobility gel shift assays were performed as described previously (Johansen et al., 2000) . Keratinocytes were cultured until 80% confluence and then medium was changed to keratinocyte basal medium for 24 hours. Then DMF, MHF, or FA was added for 1 hour before stimulation with IL-1b. In control cells only vehicle or DMF, MHF, or FA was added. Cells were collected after 0, 30, and 60 minutes stimulation. Cells were washed with ice-cold PBS buffer 2 times and kept at À801C until further treatment. Nuclear proteins were prepared as described previously (Johansen et al., 2005a, b) . Binding reactions consisted of 5 mg of nuclear protein, preincubated for 10 minutes at room temperature in the incubation buffer (5 mM MgCl 2 , 2.5 mM EDTA, 2.5 mM dithiothreitol, 250 mM NaCl, 50 mM Tris-HCl, pH 7.5, 20% glycerol, 0.25 mg/ml poly(dI-dC)). The oligonucleotides were labeled with 32 P-ATP by T4 polynucleotide kinase (Promega). Labeled oligonucleotides were purified on Nick Spin column (G-50, 17-0855-02, Pharmacia, Sweden). Then, 1.5 ml of 32 P-labeled NF-kB probe was added to the binding reactions and incubations were extended for additional 20 minutes.
Human IL-8 consensus NF-kB 5 0 -CAAATCGTGGAATTTCCTC-3 0 and human IL-20 consensus NF-kB 5 0 -GCG CTG TGG AGT CCC AGA CAC G-3 0 or NF-kB1 5 0 -GAG GAG GGG AAA CTC AGT AAG T-3 0 was purchased from DNA Technology, AIS (Aarhus, Denmark). The binding complexes were resolved on a 6% polyacrylamide gel in 0.5 Â Tris-borate-EDTA buffer (22.5 mM Tris base, 4 mM boric acid, and 1 mM EDTA).
Supershift reactions included anti-p65 antibody (sc-7151 X) and anti-p50 (sc-7178 X) antibody from Santa Cruz Biotechnology (Santa Cruz, CA). To the IL-1b-stimulated nuclear proteins in incubation buffer, 2 ml of anti-p65 antibody (or anti-p50 antibody) was added for 20 minutes before the addition of poly(dI-dC) and the radio-labeled NF-kB probe.
Isolation of RNA and quantitative reverse transcriptase-PCR
RNA was purified with SV 96 total RNA isolation system (Promega, Madison, WI). Briefly, 100 ml of SV RNA lysis buffer was added and lysates prepared by manually scraping the bottom of the wells. The lysates were transferred to sterile Eppendorf tubes and kept at À801C until RNA purification. On RNA purification the samples were carefully thawed while on ice and transferred to the wells of the SV 96-binding plates. Total RNA was purified according to the protocol as described by the manufacturer. Ultimately, RNA was dissolved in RNase/DNase-free water and stored at À801C until further use. Quantitative reverse transcriptase-PCR were performed as described previously by Otkjaer et al. (2005) and Johansen et al. (2006) . All primers and probes were Taqman 20 Â assay-on demand (FAM-labeled MGBprobes) gene expression assay mix. (assay ID: IL-20: Hs00218888_ml, IL-8: Hs00174103_ml, 18 seconds rRNA: Hs99999901_s1. (Applied Biosystems, Foster City, CA).
